Uxin (NasdaqGS:UXIN) has opened Q1 2026 with revenue of C¥1.1 billion and a net loss of C¥98.0 million, translating to a basic EPS loss of C¥0.44. The company has seen quarterly revenue move from C¥504.2 million in Q1 2025 to C¥1.1 billion in Q1 2026, while quarterly basic EPS moved from a loss of C¥0.27 to a loss of C¥0.44 over the same period. This sets up a picture in which top line scale is running ahead of progress on per share profitability. For investors, the latest print keeps the focus on whether Uxin can convert higher sales into tighter loss margins from here.

See our full analysis for Uxin.

With the headline numbers on the table, the next step is to see how Uxin’s recent results line up against the prevailing growth and risk narratives that investors have been following.

Q1 loss of C¥98 million keeps Uxin in investment phase

• On a trailing twelve month basis, Uxin reported revenue of C¥3.8b and a net loss of C¥322.5 million, compared with quarterly Q1 2026 revenue of C¥1.1b and a quarterly net loss of C¥98.0 million, so the current quarter sits within a wider period where the business is still loss making at scale.
• Bulls highlight that five year loss reduction of about 23% per year and analyst style forecasts for roughly 36% annual revenue growth with earnings expected to turn positive within three years point to Uxin using this loss making period to build a larger platform. However, the Q1 2026 loss of C¥98.0 million and trailing twelve month loss of C¥322.5 million show the company has not reached that turning point yet.
  • Supporters often point to revenue growth of about 23% per year over the last five years as evidence that the model can scale, while the C¥3.8b of trailing twelve month revenue gives that view some numerical backing.
  • At the same time, the absence of positive net income in any of the listed quarters and the trailing twelve month loss remind investors that the bullish path to profitability still involves absorbing ongoing losses.

Curious how bullish and bearish investors are connecting these Q1 figures to Uxin's long term story, and where they disagree most sharply about the path to profitability? 📊 Read the what the Community is saying about Uxin.

Loss per share widens to C¥0.44

• Basic EPS moved from a loss of C¥0.27 in Q1 2025 to a loss of C¥0.44 in Q1 2026, and on a trailing twelve month basis sits at a loss of C¥1.49 per share, which is a wider per share loss than the C¥0.40 to C¥0.48 range seen in the last few individual quarters.
• For investors taking a more cautious, bearish stance, the combination of a C¥1.49 trailing twelve month loss per share and ongoing quarterly losses between C¥0.27 and C¥0.48 per share challenges the idea that Uxin is close to consistent profitability, even with forecasts pointing to a transition to positive earnings within three years.
  • Critics point out that net losses ranged from C¥53.1 million to C¥98.0 million across the six listed quarters, so the per share loss pattern is not yet showing a clear, steady move toward breakeven.
  • They also note that with the stock at C¥1.90 and an allowed analyst style target of C¥4.00, the implied upside rests on a material EPS shift from a C¥1.49 trailing twelve month loss, which has not appeared in the reported numbers so far.

Premium P/S and short cash runway

• Uxin trades on a P/S of 0.9x compared with a cited peer and US Specialty Retail industry average of 0.4x, and trailing twelve month data indicate the company has less than one year of cash runway, so investors are weighing a higher revenue based valuation alongside a clear financing constraint.
• Consensus style commentary argues that growth metrics help explain the richer P/S multiple, but also flags the under one year cash runway as a key risk that could matter if forecasted revenue growth of roughly 36% per year and the shift to profitability within three years do not appear in reported figures on schedule.
  • Supporters of the growth case often reference five year revenue growth of about 23% per year and the C¥3.8b trailing twelve month revenue as a base that might support the 0.9x P/S, relative to peers on 0.4x.
  • More cautious investors focus on the under one year cash runway from trailing twelve month data, since any need to raise capital to fund continued losses of C¥322.5 million over the last twelve months could influence both dilution and how the valuation multiple is interpreted.

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Uxin on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

With a mix of optimism and concern running through this Uxin update, it is worth checking the underlying numbers yourself and deciding how convincing the story feels. To weigh those trade offs in more detail and see how risk and reward stack up side by side, take a closer look at the 2 key rewards and 1 important warning sign.

See What Else Is Out There

Uxin is still reporting losses at both net income and EPS level, with a short cash runway and no clear, consistent path toward profitability yet.

If you are concerned about ongoing losses and funding risk, it is worth checking companies screened for stronger balance sheets and cash cushions through the solid balance sheet and fundamentals stocks screener (48 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.